Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × dexamethasone 21-phosphate × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 9 Burkitt Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Biphenotypic, Acute 3 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Smoldering Multiple Myeloma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Fatigue 1 Down Syndrome 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Rituximab 14 CT-P10 6 ibrutinib 5 Magnetic Resonance Spectroscopy 5 Cyclophosphamide 5 zanubrutinib 4 venetoclax 4 pirtobrutinib 4 glofitamab 4 fludarabine 4 Lenalidomide 4 Specimen Handling 3 obinutuzumab 2 fludarabine phosphate 2 acalabrutinib 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Cytarabine 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1 tislelizumab 1 palbociclib 1 ixazomib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Watchful Waiting 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡